{ "schema_version": "4.0", "title": "The Land of Monopoly — corporate family atlas", "reviewed": "2026-10-08", "scope": "Selected U.S.-relevant and global brands, medicines, acquired companies, media properties and business units. Portfolio, commercial, governance and historical relationships are separately typed and dated.", "sectors": [ "Food + drink", "Household + personal", "Seeds + agrochemicals", "Healthcare", "Finance", "Energy", "Defense", "News + media", "Digital platforms" ], "groups": [ { "id": "pepsico", "name": "PepsiCo", "sectors": [ "Food + drink" ], "ownership_structure": "Publicly traded parent company", "children": [ { "name": "Pepsi", "type": "brand" }, { "name": "Lay’s", "type": "brand" }, { "name": "Doritos", "type": "brand" }, { "name": "Cheetos", "type": "brand" }, { "name": "Tostitos", "type": "brand" }, { "name": "Fritos", "type": "brand" }, { "name": "Gatorade", "type": "brand" }, { "name": "Aquafina", "type": "brand" }, { "name": "Quaker", "type": "brand" }, { "name": "Mountain Dew", "type": "brand" }, { "name": "Siete", "type": "brand" }, { "name": "Poppi", "type": "brand" } ], "note": "Switching between these brands keeps the purchase within the PepsiCo brand portfolio. Retailers and distributors also receive a portion of a retail purchase.", "sources": [ { "title": "Company portfolio / business source", "url": "https://www.pepsico.com/en/brands" }, { "title": "Quaker", "url": "https://www.pepsico.com/en/brands/quaker" }, { "title": "Mountain Dew", "url": "https://www.pepsico.com/en/brands/mountain-dew" } ], "reviewed": "2026-10-08" }, { "id": "coca-cola", "name": "The Coca-Cola Company", "sectors": [ "Food + drink" ], "ownership_structure": "Publicly traded parent company", "children": [ { "name": "Coca-Cola", "type": "brand" }, { "name": "Diet Coke", "type": "brand" }, { "name": "Sprite", "type": "brand" }, { "name": "Fanta", "type": "brand" }, { "name": "Dasani", "type": "brand" }, { "name": "Powerade", "type": "brand" }, { "name": "smartwater", "type": "brand" }, { "name": "Topo Chico", "type": "brand" }, { "name": "Minute Maid", "type": "brand" }, { "name": "Simply", "type": "brand" }, { "name": "fairlife", "type": "brand" }, { "name": "Gold Peak", "type": "brand" } ], "note": "Brand ownership differs from ownership of a local bottler, distributor, or shop. This selection covers nonalcoholic beverages.", "sources": [ { "title": "Company portfolio / business source", "url": "https://www.coca-colacompany.com/brands" } ], "reviewed": "2026-10-08" }, { "id": "nestle", "name": "Nestlé", "sectors": [ "Food + drink" ], "ownership_structure": "Publicly traded parent company", "children": [ { "name": "Nescafé", "type": "brand" }, { "name": "Coffee mate", "type": "brand" }, { "name": "Nesquik", "type": "brand" }, { "name": "DiGiorno", "type": "brand" }, { "name": "Stouffer’s", "type": "brand" }, { "name": "Hot Pockets", "type": "brand" }, { "name": "Lean Cuisine", "type": "brand" }, { "name": "Toll House", "type": "brand" }, { "name": "Gerber", "type": "brand" }, { "name": "Purina", "type": "brand" }, { "name": "Perrier", "type": "brand" }, { "name": "Sanpellegrino", "type": "brand" } ], "note": "U.S.-relevant selection. Regional trademark and licensing arrangements can differ; this map excludes KitKat and other potentially misleading cross-market shortcuts.", "sources": [ { "title": "Company portfolio / business source", "url": "https://www.nestleusa.com/brands" } ], "reviewed": "2026-10-08" }, { "id": "mondelez", "name": "Mondelēz International", "sectors": [ "Food + drink" ], "ownership_structure": "Publicly traded parent company", "children": [ { "name": "Oreo", "type": "brand" }, { "name": "Ritz", "type": "brand" }, { "name": "Chips Ahoy!", "type": "brand" }, { "name": "Triscuit", "type": "brand" }, { "name": "Wheat Thins", "type": "brand" }, { "name": "Honey Maid", "type": "brand" }, { "name": "belVita", "type": "brand" }, { "name": "CLIF", "type": "brand" }, { "name": "Tate’s Bake Shop", "type": "brand" }, { "name": "Sour Patch Kids", "type": "brand" }, { "name": "Hu", "type": "brand" }, { "name": "Toblerone", "type": "brand" } ], "note": "Selected U.S.-familiar portfolio brands. Cadbury and Philadelphia are omitted because rights differ across markets.", "sources": [ { "title": "Company portfolio / business source", "url": "https://www.mondelezinternational.com/our-brands/" } ], "reviewed": "2026-10-08" }, { "id": "general-mills", "name": "General Mills", "sectors": [ "Food + drink" ], "ownership_structure": "Publicly traded parent company", "children": [ { "name": "Cheerios", "type": "brand" }, { "name": "Annie’s", "type": "brand" }, { "name": "Betty Crocker", "type": "brand" }, { "name": "Bisquick", "type": "brand" }, { "name": "Blue Buffalo", "type": "brand" }, { "name": "Bugles", "type": "brand" }, { "name": "Cascadian Farm", "type": "brand" }, { "name": "Chex Cereal", "type": "brand" }, { "name": "Chex Mix", "type": "brand" }, { "name": "Cinnamon Toast Crunch", "type": "brand" }, { "name": "Cocoa Puffs", "type": "brand" } ], "note": "Selected brands from General Mills’ company directory.", "sources": [ { "title": "Company portfolio / business source", "url": "https://www.generalmills.com/our-food/brands" } ], "reviewed": "2026-10-08" }, { "id": "conagra", "name": "Conagra Brands", "sectors": [ "Food + drink" ], "ownership_structure": "Publicly traded parent company", "children": [ { "name": "Birds Eye (U.S.)", "type": "brand" }, { "name": "Vlasic", "type": "brand" }, { "name": "Angie’s BOOMCHICKAPOP", "type": "brand" }, { "name": "Banquet", "type": "brand" }, { "name": "DAVID Seeds", "type": "brand" }, { "name": "Duke’s Shorty Sausages", "type": "brand" }, { "name": "Blake’s", "type": "brand" }, { "name": "BIGS", "type": "brand" } ], "note": "Birds Eye is shown for the United States. The same brand name can have different owners in other territories.", "sources": [ { "title": "Company portfolio / business source", "url": "https://www.conagrabrands.com/brands" } ], "reviewed": "2026-10-08" }, { "id": "mars", "name": "Mars, Incorporated", "sectors": [ "Food + drink" ], "ownership_structure": "Privately held, family-owned company", "children": [ { "name": "M&M’s", "type": "brand" }, { "name": "Snickers", "type": "brand" }, { "name": "Skittles", "type": "brand" }, { "name": "Extra", "type": "brand" }, { "name": "Ben’s Original", "type": "brand" }, { "name": "Pedigree", "type": "brand" }, { "name": "Royal Canin", "type": "brand" }, { "name": "Pringles", "via": "Kellanova", "type": "brand" }, { "name": "Cheez-It", "via": "Kellanova", "type": "brand" }, { "name": "Pop-Tarts", "via": "Kellanova", "type": "brand" }, { "name": "Rice Krispies Treats", "via": "Kellanova", "type": "brand" }, { "name": "RXBAR", "via": "Kellanova", "type": "brand" } ], "note": "Mars completed its Kellanova acquisition on December 11, 2025. The acquired portfolio includes snack brands and international cereal rights; geographic rights are specified in the individual records.", "sources": [ { "title": "Company portfolio / business source", "url": "https://www.mars.com/our-brands" }, { "title": "Completed Kellanova acquisition", "url": "https://www.mars.com/en-be/news-and-stories/press-releases-statements/mars-completes-acquisition-of-kellanova" } ], "reviewed": "2026-10-08" }, { "id": "unilever", "name": "Unilever", "sectors": [ "Household + personal", "Food + drink" ], "ownership_structure": "Publicly traded parent company", "children": [ { "name": "Dove (personal care)", "type": "brand" }, { "name": "Vaseline", "type": "brand" }, { "name": "Axe", "type": "brand" }, { "name": "TRESemmé", "type": "brand" }, { "name": "Liquid I.V.", "type": "brand" }, { "name": "Lifebuoy", "type": "brand" }, { "name": "Rexona", "type": "brand" }, { "name": "Comfort", "type": "brand" }, { "name": "Hellmann’s", "type": "brand" }, { "name": "Knorr", "type": "brand" } ], "note": "The Foods combination with McCormick is announced, with completion expected by mid-2027, subject to conditions. The map retains current ownership. Ice cream became a separate listed group in December 2025.", "sources": [ { "title": "Company portfolio / business source", "url": "https://www.unilever.com/brands" }, { "title": "Proposed Foods combination", "url": "https://www.unilever.com/investors/unilever-foods-to-combine-with-mccormick/" }, { "title": "July 2026 transaction update", "url": "https://ir.mccormick.com/news-releases/news-release-details/mccormick-announces-operating-model-executive-team-and-secondary" }, { "title": "June 2026 filing: retained Magnum stake", "url": "https://www.sec.gov/Archives/edgar/data/217410/000021741026000057/R13.htm" } ], "reviewed": "2026-10-08" }, { "id": "magnum", "name": "The Magnum Ice Cream Company", "sectors": [ "Food + drink" ], "ownership_structure": "Publicly traded parent company", "children": [ { "name": "Magnum", "type": "brand" }, { "name": "Ben & Jerry’s", "type": "brand" }, { "name": "Breyers", "type": "brand" }, { "name": "Klondike", "type": "brand" }, { "name": "Talenti", "type": "brand" }, { "name": "Yasso", "type": "brand" }, { "name": "Cornetto", "type": "brand" }, { "name": "Wall’s", "type": "brand" } ], "note": "A separate listed company following the December 2025 demerger. Unilever reported a retained 19.85% minority equity investment in its June 2026 filing.", "sources": [ { "title": "Company portfolio / business source", "url": "https://corporate.magnumicecream.com/en/brands.html" }, { "title": "Demerger information", "url": "https://www.unilever.com/investors/the-magnum-ice-cream-company-demerger/" }, { "title": "June 2026 minority holding", "url": "https://www.sec.gov/Archives/edgar/data/217410/000021741026000057/R13.htm" } ], "reviewed": "2026-10-08" }, { "id": "pg", "name": "Procter & Gamble", "sectors": [ "Household + personal" ], "ownership_structure": "Publicly traded parent company", "children": [ { "name": "Tide", "type": "brand" }, { "name": "Gain", "type": "brand" }, { "name": "Downy", "type": "brand" }, { "name": "Dawn", "type": "brand" }, { "name": "Cascade", "type": "brand" }, { "name": "Febreze", "type": "brand" }, { "name": "Swiffer", "type": "brand" }, { "name": "Pampers", "type": "brand" }, { "name": "Bounty", "type": "brand" }, { "name": "Charmin", "type": "brand" }, { "name": "Gillette", "type": "brand" }, { "name": "Crest", "type": "brand" }, { "name": "Oral-B", "type": "brand" }, { "name": "Olay", "type": "brand" }, { "name": "Old Spice", "type": "brand" }, { "name": "Native", "type": "brand" } ], "note": "Procter & Gamble’s selected portfolio spans household cleaning, hygiene, grooming and personal care.", "sources": [ { "title": "Company portfolio / business source", "url": "https://us.pg.com/brands/" } ], "reviewed": "2026-10-08" }, { "id": "uhg", "name": "UnitedHealth Group", "sectors": [ "Healthcare" ], "ownership_structure": "Publicly traded parent company", "children": [ { "name": "UnitedHealthcare", "type": "business" }, { "name": "Optum", "type": "business" }, { "name": "Optum Rx", "type": "business", "via": "Optum" } ], "note": "Insurance and health-services businesses belong to the same parent. A patient may have limited choice because of employer or plan contracts.", "sources": [ { "title": "Company portfolio / business source", "url": "https://www.unitedhealthgroup.com/uhg/businesses.html" } ], "reviewed": "2026-10-08" }, { "id": "cvs", "name": "CVS Health", "sectors": [ "Healthcare" ], "ownership_structure": "Publicly traded parent company", "children": [ { "name": "Aetna", "type": "business" }, { "name": "CVS Pharmacy", "type": "business" }, { "name": "CVS Caremark", "type": "business" } ], "note": "CVS Health combines the Aetna insurance business, CVS Pharmacy and the CVS Caremark pharmacy-benefit manager.", "sources": [ { "title": "Company portfolio / business source", "url": "https://www.cvshealth.com/" } ], "reviewed": "2026-10-08" }, { "id": "cigna", "name": "The Cigna Group", "sectors": [ "Healthcare" ], "ownership_structure": "Publicly traded parent company", "children": [ { "name": "Cigna Healthcare", "type": "business" }, { "name": "Evernorth", "type": "business" }, { "name": "Express Scripts", "type": "business", "via": "Evernorth" }, { "name": "Accredo", "type": "business", "via": "Evernorth" } ], "note": "Cigna Healthcare provides insurance; Evernorth houses health services including Express Scripts and specialty pharmacy Accredo. HCSC acquired the former Cigna Medicare and CareAllies businesses in March 2025.", "sources": [ { "title": "Company portfolio / business source", "url": "https://www.thecignagroup.com/our-capabilities/evernorth-health-services" }, { "title": "Cigna group divisions", "url": "https://www.thecignagroup.com/our-capabilities/" }, { "title": "Completed Medicare and CareAllies sale, March 2025", "url": "https://www.hcsc.com/newsroom/news-releases/2025/completes-cigna-medicare-acquisition" } ], "reviewed": "2026-10-08" }, { "id": "jpm", "name": "JPMorgan Chase & Co.", "sectors": [ "Finance" ], "ownership_structure": "Publicly traded parent company", "children": [ { "name": "Chase", "type": "business brand" }, { "name": "J.P. Morgan", "type": "business brand" } ], "note": "Consumer and institutional business brands within one banking group. Deposits, investment products, and advisory mandates have different legal and economic relationships.", "sources": [ { "title": "Company portfolio / business source", "url": "https://www.jpmorganchase.com/about" } ], "reviewed": "2026-10-08" }, { "id": "bofa", "name": "Bank of America Corporation", "sectors": [ "Finance" ], "ownership_structure": "Publicly traded parent company", "children": [ { "name": "Bank of America", "type": "business brand" }, { "name": "Merrill", "type": "business brand" }, { "name": "BofA Securities", "type": "business brand" }, { "name": "Bank of America Private Bank", "type": "business brand" } ], "note": "Selected corporate affiliates and business brands within Bank of America.", "sources": [ { "title": "Company portfolio / business source", "url": "https://www.bankofamerica.com/security-center/affiliate-companies/" } ], "reviewed": "2026-10-08" }, { "id": "exxon", "name": "Exxon Mobil Corporation", "sectors": [ "Energy" ], "ownership_structure": "Publicly traded parent company", "children": [ { "name": "Exxon", "type": "brand" }, { "name": "Mobil", "type": "brand" }, { "name": "Esso", "type": "brand" } ], "note": "Fuel brands connect to ExxonMobil through a combination of ownership, distribution and supply arrangements. Individual branded stations may have independent owners.", "sources": [ { "title": "Company portfolio / business source", "url": "https://corporate.exxonmobil.com/who-we-are/our-global-organization/brands" } ], "reviewed": "2026-10-08" }, { "id": "chevron", "name": "Chevron Corporation", "sectors": [ "Energy" ], "ownership_structure": "Publicly traded parent company", "children": [ { "name": "Chevron", "type": "brand" }, { "name": "Texaco", "type": "brand" }, { "name": "Caltex", "type": "brand" } ], "note": "Chevron’s fuel brands use licensing, supply and franchise arrangements. Individual station ownership is a separate part of the distribution chain.", "sources": [ { "title": "Company portfolio / business source", "url": "https://www.chevron.com/who-we-are/our-brands" } ], "reviewed": "2026-10-08" }, { "id": "rtx", "name": "RTX Corporation", "sectors": [ "Defense" ], "ownership_structure": "Publicly traded parent company", "children": [ { "name": "Raytheon", "type": "business segment" }, { "name": "Pratt & Whitney", "type": "business segment" }, { "name": "Collins Aerospace", "type": "business segment" } ], "note": "Government and institutional procurement matter more here than ordinary retail purchasing. Civil aviation operations are also part of these businesses.", "sources": [ { "title": "Company portfolio / business source", "url": "https://www.rtx.com/who-we-are/our-businesses" } ], "reviewed": "2026-10-08" }, { "id": "lockheed", "name": "Lockheed Martin", "sectors": [ "Defense" ], "ownership_structure": "Publicly traded parent company", "children": [ { "name": "Aeronautics", "type": "business area" }, { "name": "Missiles and Fire Control", "type": "business area" }, { "name": "Rotary and Mission Systems", "type": "business area" }, { "name": "Space", "type": "business area" }, { "name": "Sikorsky", "type": "business", "via": "Rotary and Mission Systems" } ], "note": "These nodes are business areas and a company within the group, rather than consumer product brands.", "sources": [ { "title": "Company portfolio / business source", "url": "https://www.lockheedmartin.com/en-us/who-we-are/business-areas.html" }, { "title": "Sikorsky within Rotary and Mission Systems", "url": "https://www.lockheedmartin.com/en-us/who-we-are/business-areas/rotary-and-mission-systems.html" } ], "reviewed": "2026-10-08" }, { "id": "pfizer", "name": "Pfizer", "sectors": [ "Healthcare" ], "reviewed": "2026-10-08", "ownership_structure": "Publicly traded — NYSE: PFE", "children": [ { "name": "Paxlovid", "type": "Marketed product", "relation": "portfolio" }, { "name": "Ibrance", "type": "Marketed product", "relation": "portfolio" }, { "name": "Prevnar 20", "type": "Marketed product", "relation": "portfolio" }, { "name": "Seagen", "type": "Acquired business", "relation": "acquired_business", "note": "Pfizer completed the Seagen acquisition in December 2023." }, { "name": "Comirnaty", "type": "Collaborative product", "relation": "collaboration", "note": "Pfizer and BioNTech collaborate on Comirnaty. BioNTech is the marketing authorization holder in the United States, EU, UK and other countries; the companies are separate." } ], "note": "Selected U.S. medicines and acquired businesses. Comirnaty is developed and commercialized with BioNTech; product rights and marketing authorizations vary by territory.", "sources": [ { "title": "Pfizer — U.S. product directory", "url": "https://www.pfizer.com/products" }, { "title": "Pfizer completes acquisition of Seagen — December 2023", "url": "https://www.pfizer.com/news/press-release/press-release-detail/pfizer-completes-acquisition-seagen" }, { "title": "Pfizer/BioNTech joint release — August 27, 2026", "url": "https://www.pfizer.com/news/press-release/press-release-detail/pfizer-and-biontech-receive-us-fda-approval-xfg-adapted" } ] }, { "id": "moderna", "name": "Moderna", "sectors": [ "Healthcare" ], "reviewed": "2026-10-08", "ownership_structure": "Publicly traded — Nasdaq: MRNA", "children": [ { "name": "Spikevax", "type": "Marketed product", "relation": "portfolio" }, { "name": "mNEXSPIKE", "type": "Marketed product", "relation": "portfolio" }, { "name": "mRESVIA", "type": "Marketed product", "relation": "portfolio" } ], "note": "Moderna’s selected marketed vaccine brands include Spikevax, mNEXSPIKE and mRESVIA. Product approvals and availability vary by country.", "sources": [ { "title": "Moderna — U.S. products", "url": "https://www.modernatx.com/en-US/products" }, { "title": "Moderna — SEC 8-K, July 31, 2026", "url": "https://www.sec.gov/Archives/edgar/data/1682852/000168285226000147/mrna-20260731.htm" } ] }, { "id": "biontech", "name": "BioNTech", "sectors": [ "Healthcare" ], "reviewed": "2026-10-08", "ownership_structure": "Publicly traded — Nasdaq: BNTX", "children": [ { "name": "Comirnaty", "type": "Collaborative product", "relation": "collaboration", "note": "BioNTech and Pfizer collaborate on Comirnaty. BioNTech holds the marketing authorization in the United States, EU, UK and other countries." }, { "name": "InstaDeep", "type": "Subsidiary", "relation": "subsidiary", "note": "BioNTech completed its acquisition of InstaDeep in July 2023." }, { "name": "Biotheus", "type": "Indirect subsidiary", "relation": "subsidiary", "note": "BioNTech completed the acquisition of all issued Biotheus share capital in February 2025; Biotheus became an indirect Chinese subsidiary." } ], "note": "BioNTech and Pfizer collaborate on Comirnaty while remaining separate companies. BioNTech acquired InstaDeep in 2023 and Biotheus in 2025. These corporate relationships are distinct from product-development partnerships.", "sources": [ { "title": "Pfizer/BioNTech joint release — August 27, 2026", "url": "https://www.pfizer.com/news/press-release/press-release-detail/pfizer-and-biontech-receive-us-fda-approval-xfg-adapted" }, { "title": "BioNTech completes acquisition of InstaDeep — July 31, 2023", "url": "https://www.biontech.com/int/en/home/mediaroom/news/press-releases/2023/07/biontech-completes-acquisition-instadeep.html" }, { "title": "BioNTech completes acquisition of Biotheus — February 3, 2025", "url": "https://www.biontech.com/int/en/home/mediaroom/news/press-releases/2025/02/biontech-completes-acquisition-biotheus.html" } ] }, { "id": "jnj", "name": "Johnson & Johnson", "sectors": [ "Healthcare" ], "reviewed": "2026-10-08", "ownership_structure": "Publicly traded — NYSE: JNJ", "children": [ { "name": "Stelara", "type": "Marketed product", "relation": "portfolio" }, { "name": "Tremfya", "type": "Marketed product", "relation": "portfolio", "note": "J&J lists a MorphoSys relationship for Tremfya in its partnership and licensing disclosures." }, { "name": "Spravato", "type": "Marketed product", "relation": "portfolio", "note": "J&J's partnership and licensing disclosures identify Mount Sinai, NIH and Yale relationships for Spravato." }, { "name": "J&J MedTech", "type": "Business segment", "relation": "portfolio", "note": "MedTech is a J&J operating segment." } ], "note": "J&J operates through Innovative Medicine and MedTech. Its consumer-health business separated as Kenvue in 2023; J&J disposed of its remaining Kenvue shares in May 2024. Medicine rights may include development or licensing agreements and vary by territory.", "sources": [ { "title": "Johnson & Johnson — Q2 2026 results", "url": "https://www.jnj.com/media-center/press-releases/johnson-johnson-reports-q2-2026-results-raises-2026-outlook" }, { "title": "J&J — development pipeline and collaboration disclosures, July 15, 2026", "url": "https://www.investor.jnj.com/pipeline/development-pipeline/default.aspx?a=Immunology%3BInfectious+Diseases+and+Vaccines+Global+Public+Health%3BOncology" }, { "title": "Johnson & Johnson — 2025 Form 10-K", "url": "https://www.sec.gov/Archives/edgar/data/200406/000020040626000016/jnj-20251228.htm" } ] }, { "id": "merck-msd", "name": "Merck & Co. / MSD", "sectors": [ "Healthcare" ], "reviewed": "2026-10-08", "ownership_structure": "Publicly traded — NYSE: MRK", "children": [ { "name": "Keytruda", "type": "Marketed product", "relation": "portfolio" }, { "name": "Gardasil 9", "type": "Marketed product", "relation": "portfolio" }, { "name": "Januvia", "type": "Marketed product", "relation": "portfolio" }, { "name": "Belsomra", "type": "Marketed product", "relation": "portfolio" } ], "note": "Merck & Co. uses the MSD name outside the United States and Canada. The U.S.-based group and Germany’s Merck KGaA operate as separate companies. Selected brands follow the U.S. product directory.", "sources": [ { "title": "Merck & Co. — U.S. product list", "url": "https://www.merck.com/products/" }, { "title": "Merck & Co. — Q2 2026 results and MSD name geography", "url": "https://www.merck.com/news/merck-highlights-key-regulatory-and-clinical-milestones-across-broad-diverse-pipeline/" }, { "title": "Merck KGaA — our name and brand; two unaffiliated companies", "url": "https://www.merckgroup.com/en/company/our-name-and-brand.html" } ] }, { "id": "abbvie", "name": "AbbVie", "sectors": [ "Healthcare" ], "reviewed": "2026-10-08", "ownership_structure": "Publicly traded — NYSE: ABBV", "children": [ { "name": "Humira", "type": "Marketed product", "relation": "portfolio" }, { "name": "Rinvoq", "type": "Marketed product", "relation": "portfolio" }, { "name": "Botox", "type": "Marketed product", "relation": "portfolio", "note": "AbbVie reports Botox Therapeutic and Botox Cosmetic revenues. The Botox business entered AbbVie's portfolio through its Allergan acquisition." }, { "name": "Allergan", "type": "Acquired business", "relation": "acquired_business" } ], "note": "AbbVie’s medicine and aesthetics portfolios include acquired and licensed products. Allergan is part of AbbVie. Technology rights, product names and commercial territories are governed by the relevant acquisition and licensing agreements.", "sources": [ { "title": "AbbVie — Q2 2026 results and product revenue table", "url": "https://investors.abbvie.com/news-releases/news-release-details/abbvie-reports-second-quarter-2026-financial-results" }, { "title": "Allergan is now part of AbbVie", "url": "https://www.abbvie.com/allergan.html" }, { "title": "AbbVie — U.S. product information and trademark scope", "url": "https://www.abbvie.com/patients/products.html" } ] }, { "id": "lilly", "name": "Eli Lilly", "sectors": [ "Healthcare" ], "reviewed": "2026-10-08", "ownership_structure": "Publicly traded — NYSE: LLY", "children": [ { "name": "Mounjaro", "type": "Marketed product", "relation": "portfolio" }, { "name": "Zepbound", "type": "Marketed product", "relation": "portfolio" }, { "name": "Humalog", "type": "Marketed product", "relation": "portfolio" }, { "name": "Trulicity", "type": "Marketed product", "relation": "portfolio" }, { "name": "Jardiance", "type": "Collaborative product", "relation": "collaboration", "note": "Part of the collaboration with Boehringer Ingelheim. Lilly's Q2 2026 filing identifies it as Boehringer Ingelheim's Jardiance product family; commercialization responsibilities and revenue rights vary by market." } ], "note": "Mounjaro and Zepbound are brands containing tirzepatide. Jardiance is developed and commercialized through Lilly’s collaboration with Boehringer Ingelheim.", "sources": [ { "title": "Eli Lilly — current medicines", "url": "https://www.lilly.com/medicines/current" }, { "title": "Eli Lilly — Q2 2026 results", "url": "https://investor.lilly.com/news-releases/news-release-details/lilly-reports-second-quarter-2026-financial-results-raises-full" }, { "title": "Eli Lilly — Q2 2026 SEC 10-Q; Jardiance collaboration", "url": "https://www.sec.gov/Archives/edgar/data/59478/000005947826000081/lly-20260630.htm" } ] }, { "id": "roche", "name": "Roche", "sectors": [ "Healthcare" ], "reviewed": "2026-10-08", "ownership_structure": "Publicly traded; controlling shareholder voting pool", "children": [ { "name": "Genentech", "type": "Wholly owned subsidiary", "relation": "subsidiary" }, { "name": "Chugai Pharmaceutical", "type": "Majority-owned company", "relation": "subsidiary", "note": "Roche is Chugai’s majority shareholder; Chugai also has minority shareholders." }, { "name": "Ocrevus", "type": "Marketed product", "relation": "portfolio" }, { "name": "Hemlibra", "type": "Marketed product", "relation": "portfolio" } ], "note": "Roche wholly owns Genentech and holds a majority interest in Chugai. Its shareholder voting pool held 64.97% of issued voting shares at December 31, 2025; voting control differs from ownership of all economic equity. Portfolio products can involve licensed technologies or rights that differ by market.", "sources": [ { "title": "Roche — first-half 2026 results; products, Genentech and Chugai", "url": "https://www.roche.com/media/releases/med-cor-2026-07-23" }, { "title": "Roche — share and bond information; controlling shareholder pool", "url": "https://www.roche.com/investors/bonds" }, { "title": "Roche — Code of Conduct: Investors; founder-family shareholder pool", "url": "https://sp-coc.roche.com/en/investors.html" } ] }, { "id": "boehringer", "name": "Boehringer Ingelheim", "sectors": [ "Healthcare" ], "reviewed": "2026-10-08", "ownership_structure": "Privately held; family-owned", "children": [ { "name": "Ofev", "type": "Marketed product", "relation": "portfolio" }, { "name": "Spiriva", "type": "Marketed product", "relation": "portfolio" }, { "name": "Pradaxa", "type": "Marketed product", "relation": "portfolio" }, { "name": "Jardiance", "type": "Collaborative product", "relation": "collaboration", "note": "Boehringer Ingelheim's Jardiance product family is part of a collaboration with Lilly. Commercialization responsibilities and revenue rights vary by market." } ], "note": "Boehringer Ingelheim is family-owned. Jardiance is part of its collaboration with Lilly. Selected brands follow the U.S. product directory.", "sources": [ { "title": "Boehringer Ingelheim — family ownership", "url": "https://www.boehringer-ingelheim.com/us/careers/explore-our-company/family-owned" }, { "title": "Boehringer Ingelheim — who we are", "url": "https://www.boehringer-ingelheim.com/us/about-us/who-we-are" }, { "title": "Boehringer Ingelheim — current U.S. products", "url": "https://pro.boehringer-ingelheim.com/us/" }, { "title": "Eli Lilly — Q2 2026 SEC 10-Q; Jardiance collaboration", "url": "https://www.sec.gov/Archives/edgar/data/59478/000005947826000081/lly-20260630.htm" } ] }, { "id": "sanofi", "name": "Sanofi", "sectors": [ "Healthcare" ], "ownership_structure": "Publicly traded parent company", "children": [ { "name": "Lantus", "type": "Marketed product", "relation": "portfolio" }, { "name": "Toujeo", "type": "Marketed product", "relation": "portfolio" }, { "name": "Lovenox", "type": "Marketed product", "relation": "portfolio" } ], "note": "Sanofi’s history includes Hoechst through Aventis: Hoechst and Rhône-Poulenc combined in 1999, and Sanofi-Synthélabo acquired Aventis in 2004. The current portfolio shows selected U.S. marketed medicines.", "sources": [ { "title": "Sanofi U.S. prescription portfolio", "url": "https://www.sanofi.us/en/your-health/products/prescription-products" }, { "title": "Hoechst site and corporate history", "url": "https://www.industriepark-hoechst.com/en/stp/site/history/" }, { "title": "2004 Aventis filing on completed acquisition", "url": "https://www.sec.gov/Archives/edgar/data/807198/000095012304013619/x03590bexv99w1.htm" } ], "reviewed": "2026-10-08" }, { "id": "bayer", "name": "Bayer", "sectors": [ "Healthcare", "Seeds + agrochemicals" ], "ownership_structure": "Publicly traded parent company", "children": [ { "name": "Monsanto", "type": "acquired company", "relation": "acquired_business", "note": "Bayer completed its acquisition of Monsanto on June 7, 2018." }, { "name": "DEKALB", "type": "seed brand", "relation": "portfolio", "via": "Crop Science" }, { "name": "Asgrow", "type": "seed brand", "relation": "portfolio", "via": "Crop Science" }, { "name": "Channel", "type": "seed brand", "relation": "portfolio", "via": "Crop Science" }, { "name": "Deltapine", "type": "seed brand", "relation": "portfolio", "via": "Crop Science" }, { "name": "Roundup (agriculture)", "type": "herbicide brand", "relation": "portfolio", "via": "Crop Science", "note": "Agricultural herbicide brand. Formulations, registrations and consumer-product licensing vary by territory." }, { "name": "Aleve", "type": "consumer-health brand", "relation": "portfolio", "via": "Consumer Health" }, { "name": "Claritin", "type": "consumer-health brand", "relation": "portfolio", "via": "Consumer Health" }, { "name": "One A Day", "type": "supplement brand", "relation": "portfolio", "via": "Consumer Health" }, { "name": "Bayer Aspirin", "type": "consumer-health brand", "relation": "portfolio", "via": "Consumer Health" } ], "note": "Bayer spans medicines, consumer health and crop science. Its 2018 acquisition of Monsanto brought seed and crop-protection businesses into the group. Selected U.S. consumer brands are shown alongside crop-science brands; rights and availability vary by territory.", "sources": [ { "title": "Bayer U.S. consumer-health portfolio", "url": "https://www.bayer.com/en-us/united-states/products/bayer-consumer-health" }, { "title": "Bayer U.S. crop-science portfolio", "url": "https://www.cropscience.bayer.us/" }, { "title": "Monsanto acquisition completed, 2018", "url": "https://www.bayer.com/media/en-us/bayer-closes-monsanto-acquisition/" }, { "title": "Bayer corporate history", "url": "https://www.bayer.com/en/about-us/history/history-timeline" } ], "reviewed": "2026-10-08" }, { "id": "basf", "name": "BASF", "sectors": [ "Seeds + agrochemicals" ], "ownership_structure": "Publicly traded parent company", "children": [ { "name": "Nunhems", "type": "vegetable-seed brand", "relation": "portfolio", "via": "Agricultural Solutions" }, { "name": "InVigor", "type": "canola-seed brand", "relation": "portfolio", "via": "Agricultural Solutions" }, { "name": "FiberMax", "type": "cotton-seed brand", "relation": "portfolio", "via": "Agricultural Solutions" }, { "name": "Stoneville", "type": "cotton-seed brand", "relation": "portfolio", "via": "Agricultural Solutions" }, { "name": "Liberty", "type": "herbicide brand", "relation": "portfolio", "via": "Agricultural Solutions" } ], "note": "Selected brands in BASF’s agricultural portfolio. The company’s history includes the formation and postwar breakup of IG Farben. BASF acquired divested Bayer assets during the 2018 Monsanto transaction.", "sources": [ { "title": "BASF Agricultural Solutions factbook", "url": "https://www.basf.com/global/en/investors/calendar-and-publications/factbook/segments/agricultural-solutions/agricultural-solutions" }, { "title": "Acquired brands and businesses", "url": "https://www.basf.com/eg/en/products/segments/agricultural-solutions/grow-with-us/Our-new-businesses" }, { "title": "Bayer–Monsanto divestiture record", "url": "https://www.justice.gov/archives/opa/pr/justice-department-secures-largest-merger-divestiture-ever-preserve-competition-threatened" }, { "title": "BASF history of IG Farben", "url": "https://www.basf.com/global/en/who-we-are/history/IG-Farben" } ], "reviewed": "2026-10-08" }, { "id": "syngenta", "name": "Syngenta Group", "sectors": [ "Seeds + agrochemicals" ], "ownership_structure": "Sinochem-controlled group; ultimately Chinese state-owned", "children": [ { "name": "Syngenta Crop Protection", "type": "business unit", "relation": "portfolio" }, { "name": "Syngenta Seeds", "type": "business unit", "relation": "portfolio" }, { "name": "ADAMA", "type": "group business", "relation": "portfolio" }, { "name": "Syngenta Group China", "type": "business unit", "relation": "portfolio" } ], "note": "Syngenta Group operates within state-owned Sinochem Holdings. Its four principal business groups organize crop protection, seeds and its China operations.", "sources": [ { "title": "Syngenta Group business units", "url": "https://www.syngentagroup.com/" }, { "title": "Sinochem life-science businesses", "url": "https://www.sinochem.com/sinochemen/Business/Life/A046002001Gone1.html" }, { "title": "Sinochem ownership and profile", "url": "https://www.sinochem.com/sinochemen/index.html" } ], "reviewed": "2026-10-08" }, { "id": "corteva", "name": "Corteva", "sectors": [ "Seeds + agrochemicals" ], "ownership_structure": "Publicly traded — NYSE: CTVA", "children": [ { "name": "Enlist One", "type": "herbicide product", "relation": "portfolio" }, { "name": "Enlist Duo", "type": "herbicide product", "relation": "portfolio" }, { "name": "Resicore", "type": "herbicide product", "relation": "portfolio" }, { "name": "Utrisha P", "type": "biological product", "relation": "portfolio" } ], "note": "Corteva completed the separation of its seed business into Vylor on October 1, 2026. This record covers selected crop-protection products; the Vylor record contains Pioneer and Brevant. Herbicide products and seed-trait licenses carry distinct commercial rights.", "sources": [ { "title": "Corteva U.S. crop-protection products", "url": "https://www.corteva.com/us/products-and-solutions/crop-protection.html" }, { "title": "October 1, 2026 separation filing", "url": "https://www.sec.gov/Archives/edgar/data/1755672/000175567226000028/ctva-20261001.htm" } ], "reviewed": "2026-10-08" }, { "id": "vylor", "name": "Vylor", "sectors": [ "Seeds + agrochemicals" ], "ownership_structure": "Publicly traded — NYSE: VYLR", "children": [ { "name": "Pioneer", "type": "seed brand", "relation": "portfolio" }, { "name": "Brevant", "type": "seed brand", "relation": "portfolio" }, { "name": "Dairyland Seed", "type": "seed brand", "relation": "portfolio" }, { "name": "Hoegemeyer", "type": "seed brand", "relation": "portfolio" }, { "name": "Seed Consultants", "type": "seed brand", "relation": "portfolio" } ], "note": "Vylor became independent from Corteva on October 1, 2026. These seed brands are mapped to Vylor as of this edition. Historical seed-market shares attributed to Corteva describe the company before this separation.", "sources": [ { "title": "Completed separation, October 2026", "url": "https://www.sec.gov/Archives/edgar/data/1755672/000175567226000028/ctva-20261001.htm" }, { "title": "Seed portfolio in Vylor registration statement", "url": "https://www.sec.gov/Archives/edgar/data/2128626/000119312526288697/ck0002128626-ex99_1.htm" } ], "reviewed": "2026-10-08" }, { "id": "cargill", "name": "Cargill", "sectors": [ "Food + drink" ], "ownership_structure": "Privately held; family-owned", "children": [ { "name": "Nutrena", "type": "animal-feed brand", "relation": "portfolio" }, { "name": "Provimi", "type": "animal-nutrition brand", "relation": "portfolio" }, { "name": "Diamond V", "type": "animal-nutrition brand", "relation": "portfolio" }, { "name": "EWOS", "type": "aquaculture-feed brand", "relation": "portfolio" }, { "name": "Delacon", "type": "animal-nutrition brand", "relation": "portfolio" } ], "note": "A family-owned food and agricultural supplier with substantial business upstream of supermarket labels. This selection covers animal-nutrition brands.", "sources": [ { "title": "Cargill animal-nutrition brands", "url": "https://www.cargill.com/animal-nutrition" }, { "title": "Cargill company profile", "url": "https://www.cargill.com/about" } ], "reviewed": "2026-10-08" }, { "id": "elevance", "name": "Elevance Health", "sectors": [ "Healthcare" ], "ownership_structure": "Publicly traded — NYSE: ELV", "children": [ { "name": "Anthem Blue Cross / Blue Shield", "type": "health-plan brands in licensed territories", "relation": "portfolio" }, { "name": "Wellpoint", "type": "health-plan brand", "relation": "portfolio" }, { "name": "CarelonRx", "type": "pharmacy-services business", "relation": "portfolio", "via": "Carelon" }, { "name": "Carelon Services", "type": "health-services business", "relation": "portfolio", "via": "Carelon" } ], "note": "Elevance combines health plans with pharmacy, behavioral and other health services. Its Anthem-branded Blue Cross/Blue Shield plans operate in designated licensed territories; the wider Blue Cross Blue Shield Association comprises independent health plans.", "sources": [ { "title": "Elevance company portfolio", "url": "https://www.elevancehealth.com/who-we-are/companies" }, { "title": "Elevance June 2026 Form 10-Q", "url": "https://www.sec.gov/Archives/edgar/data/1156039/000115603926000060/elv-20260630.htm" } ], "reviewed": "2026-10-08" }, { "id": "humana", "name": "Humana", "sectors": [ "Healthcare" ], "ownership_structure": "Publicly traded — NYSE: HUM", "children": [ { "name": "Humana Medicare plans", "type": "insurance products", "relation": "portfolio" }, { "name": "CenterWell Pharmacy", "type": "mail-order pharmacy business", "relation": "portfolio", "via": "CenterWell" }, { "name": "CenterWell Primary Care", "type": "primary-care business", "relation": "portfolio", "via": "CenterWell" }, { "name": "CenterWell Home Health", "type": "home-health business", "relation": "portfolio", "via": "CenterWell" }, { "name": "Conviva", "type": "senior primary-care brand", "relation": "portfolio", "via": "CenterWell" } ], "note": "Humana combines insurance with CenterWell pharmacy, primary-care and home-health services. Its provider businesses also serve members of other insurers; some primary-care clinics operate through joint ventures.", "sources": [ { "title": "Humana 2025 Form 10-K: insurance and CenterWell", "url": "https://www.sec.gov/Archives/edgar/data/49071/000004907126000009/hum-20251231.htm" }, { "title": "CenterWell — Humana healthcare services", "url": "https://www.centerwellcareers.com/us/en/about-us" } ], "reviewed": "2026-10-08" }, { "id": "centene", "name": "Centene", "sectors": [ "Healthcare" ], "ownership_structure": "Publicly traded — NYSE: CNC", "children": [ { "name": "Ambetter Health", "type": "Marketplace insurance brand", "relation": "portfolio" }, { "name": "Wellcare", "type": "Medicare subsidiary and brand", "relation": "subsidiary" }, { "name": "Health Net", "type": "health-plan company", "relation": "subsidiary" } ], "note": "Centene delivers Medicaid, Medicare and Marketplace coverage through local plans and national brands. Ambetter identifies its Marketplace products, while Wellcare is its Medicare brand.", "sources": [ { "title": "Centene Ambetter Marketplace portfolio", "url": "https://www.centene.com/products-and-services/marketplace.html" }, { "title": "Wellcare ownership", "url": "https://www.wellcare.com/en/Corporate/About-Us" }, { "title": "Centene California: Health Net, Wellcare and Ambetter", "url": "https://www.centene.com/products-and-services/browse-by-state/california.html" }, { "title": "Centene 2025 results", "url": "https://investors.centene.com/2026-02-06-CENTENE-CORPORATION-REPORTS-2025-RESULTS-AND-ANNOUNCES-2026-GUIDANCE" } ], "reviewed": "2026-10-08" }, { "id": "hcsc", "name": "Health Care Service Corporation", "sectors": [ "Healthcare" ], "ownership_structure": "Mutual Legal Reserve Company", "children": [ { "name": "BCBS of Illinois", "type": "state health-plan division", "relation": "portfolio" }, { "name": "BCBS of Texas", "type": "state health-plan division", "relation": "portfolio" }, { "name": "HealthSpring", "type": "national Medicare brand", "relation": "portfolio" }, { "name": "CareAllies", "type": "wholly owned care-management subsidiary", "relation": "subsidiary" }, { "name": "Luminare Health", "type": "wholly owned benefits-administration subsidiary", "relation": "subsidiary" } ], "note": "HCSC operates Blue Cross/Blue Shield plans in Illinois, Montana, New Mexico, Oklahoma and Texas. Its March 19, 2025 purchase of Cigna’s Medicare and CareAllies businesses expanded its Medicare operations, now marketed through HealthSpring.", "sources": [ { "title": "HCSC legal structure and profile", "url": "https://www.hcsc.com/who-we-are" }, { "title": "HCSC health plans, affiliates and subsidiaries", "url": "https://www.hcsc.com/who-we-are/affiliates-subsidiaries" }, { "title": "Completed Cigna Medicare and CareAllies acquisition", "url": "https://www.hcsc.com/newsroom/news-releases/2025/completes-cigna-medicare-acquisition" } ], "reviewed": "2026-10-08" }, { "id": "skydance", "name": "Skydance", "sectors": [ "News + media" ], "ownership_structure": "Publicly traded — NYSE: SKYD; Ellison family and RedBird hold the voting Class A shares", "children": [ { "name": "CBS News", "type": "news brand", "relation": "portfolio" }, { "name": "CNN", "type": "news brand", "relation": "portfolio" }, { "name": "Paramount+", "type": "streaming service", "relation": "portfolio" }, { "name": "HBO Max", "type": "streaming service", "relation": "portfolio" } ], "note": "Paramount completed its acquisition of Warner Bros. Discovery on October 6, 2026 and renamed the combined company Skydance. CBS News and CNN now share this corporate parent. The closing release identifies the Ellison family and RedBird as the sole holders of the combined company’s voting shares.", "sources": [ { "title": "Skydance merger completion release, October 6, 2026", "url": "https://www.sec.gov/Archives/edgar/data/2041610/000110465926113913/tm2626659d7_ex99-1.htm" } ], "reviewed": "2026-10-08" }, { "id": "fox", "name": "Fox Corporation", "sectors": [ "News + media" ], "ownership_structure": "Publicly traded — FOX / FOXA; dual-class shares and a large Murdoch-family voting block", "children": [ { "name": "FOX News", "type": "news brand", "relation": "portfolio" }, { "name": "FOX Business", "type": "news brand", "relation": "portfolio" }, { "name": "FOX Nation", "type": "subscription service", "relation": "portfolio" }, { "name": "Tubi", "type": "streaming service", "relation": "portfolio" } ], "note": "The September 2026 proxy lists LGC Holdco with 38.76% of Class B shares. Voting decisions for that block are generally assigned to a Cruden 2 managing director appointed by Lachlan Murdoch. Fox and News Corp are separate listed companies connected through that shareholding structure and overlapping leadership.", "sources": [ { "title": "Fox fiscal 2026 annual report: portfolio and News Corp connections", "url": "https://www.sec.gov/Archives/edgar/data/1754301/000162828026053960/fox-20260630.htm" }, { "title": "Fox 2026 proxy: Class B voting rights and LGC Holdco", "url": "https://www.sec.gov/Archives/edgar/data/1754301/000162828026062480/fox-20260917.htm" } ], "reviewed": "2026-10-08" }, { "id": "newscorp", "name": "News Corp", "sectors": [ "News + media" ], "ownership_structure": "Publicly traded — NWS / NWSA; dual-class shares and a large Murdoch-family voting block", "children": [ { "name": "The Wall Street Journal", "type": "news publication", "relation": "portfolio", "via": "Dow Jones" }, { "name": "Barron’s", "type": "news publication", "relation": "portfolio", "via": "Dow Jones" }, { "name": "MarketWatch", "type": "news website", "relation": "portfolio", "via": "Dow Jones" }, { "name": "New York Post", "type": "news publication", "relation": "portfolio" } ], "note": "The September 2026 proxy lists LGC Holdco with 34.8% of Class B shares. The managing director of Cruden 2 appointed by Lachlan Murdoch generally directs votes for that block. Dow Jones houses several financial-news brands inside this corporate group.", "sources": [ { "title": "News Corp fiscal 2026 annual report: Dow Jones and publishing portfolio", "url": "https://www.sec.gov/Archives/edgar/data/1564708/000156470826000175/nws-20260630.htm" }, { "title": "News Corp 2026 proxy: LGC Holdco and voting rights", "url": "https://www.sec.gov/Archives/edgar/data/1564708/000110465926109969/tm2624691-1_def14a.htm" } ], "reviewed": "2026-10-08" }, { "id": "disney", "name": "The Walt Disney Company", "sectors": [ "News + media" ], "ownership_structure": "Publicly traded — NYSE: DIS", "children": [ { "name": "ABC", "type": "television network", "relation": "portfolio" }, { "name": "ABC News", "type": "news brand", "relation": "portfolio" }, { "name": "ESPN", "type": "sports media business", "relation": "majority-owned", "note": "Disney 72%; Hearst 18%; NFL 10%, following January 31, 2026 transaction." } ], "note": "Disney owns ABC and ABC News. Its effective interest in ESPN became 72% after ESPN acquired specified NFL media assets on January 31, 2026; Hearst holds 18% and the NFL 10%. The ownership split illustrates why portfolio connections can include minority equity as well as full ownership.", "sources": [ { "title": "Disney Entertainment leadership, March 16, 2026", "url": "https://investors.thewaltdisneycompany.com/news/news-details/2026/The-Walt-Disney-Company-Sets-Leadership-Team-for-Expanded-Disney-Entertainment-Segment/default.aspx" }, { "title": "Disney June 2026 quarterly report: ESPN equity ownership", "url": "https://www.sec.gov/Archives/edgar/data/1744489/000174448926000057/dis-20260627.htm" } ], "reviewed": "2026-10-08" }, { "id": "comcast", "name": "Comcast", "sectors": [ "News + media" ], "ownership_structure": "Publicly traded — Nasdaq: CMCSA; Brian Roberts holds enhanced voting rights", "children": [ { "name": "NBC News", "type": "news division", "relation": "portfolio", "via": "NBCUniversal" }, { "name": "Telemundo", "type": "television network", "relation": "portfolio", "via": "NBCUniversal" }, { "name": "Peacock", "type": "streaming service", "relation": "portfolio", "via": "NBCUniversal" }, { "name": "Sky", "type": "media and distribution business", "relation": "portfolio" } ], "note": "NBCUniversal and Sky remain mapped to Comcast in this edition. Comcast announced a proposed spin-off on June 29, 2026, with completion expected in approximately one year and subject to conditions. Brian Roberts’s Class B shares carry generally non-dilutable one-third voting power.", "sources": [ { "title": "Comcast proposed NBCUniversal/Sky separation, June 29, 2026", "url": "https://www.sec.gov/Archives/edgar/data/1166691/000095010326009591/dp249094_ex9901.htm" }, { "title": "Comcast 2026 proxy: Brian Roberts voting rights", "url": "https://www.sec.gov/Archives/edgar/data/1166691/000119312526177138/cmcsa-20260424.htm" }, { "title": "NBCUniversal company news and brands, October 2026", "url": "https://www.nbcuniversal.com/" }, { "title": "Comcast company brands and NBC centenary", "url": "https://corporate.comcast.com/press/releases/celebrating-100-years-of-nbc-today-looks-back-at-a-century-of-broadcast" } ], "reviewed": "2026-10-08" }, { "id": "versant", "name": "Versant Media Group", "sectors": [ "News + media" ], "ownership_structure": "Publicly traded — Nasdaq: VSNT; Brian Roberts holds enhanced voting rights", "children": [ { "name": "MS NOW", "type": "news network", "relation": "portfolio", "note": "Formerly MSNBC." }, { "name": "CNBC", "type": "business news network", "relation": "portfolio" }, { "name": "USA Network", "type": "television network", "relation": "portfolio" }, { "name": "E!", "type": "entertainment network", "relation": "portfolio" } ], "note": "Versant became independent of Comcast on January 2, 2026. The retained overlap is at the shareholder level: Brian Roberts’s Class B shares carry generally non-dilutable one-third voting power in Versant as well as in Comcast. CNBC operates under a trademark license from Comcast.", "sources": [ { "title": "Versant 2025 annual report, filed March 2026: separation, portfolio and voting", "url": "https://www.sec.gov/Archives/edgar/data/2067876/000206787626000010/vsnt-20251231.htm" }, { "title": "Versant 2026 proxy: Brian Roberts voting rights", "url": "https://www.sec.gov/Archives/edgar/data/2067876/000206787626000019/vsnt-20260422.htm" } ], "reviewed": "2026-10-08" }, { "id": "nytimes", "name": "The New York Times Company", "sectors": [ "News + media" ], "ownership_structure": "Publicly traded — NYSE: NYT; Ochs-Sulzberger family trust controls board elections", "children": [ { "name": "The New York Times", "type": "news publication", "relation": "portfolio" }, { "name": "The Athletic", "type": "sports publication", "relation": "portfolio" }, { "name": "Wirecutter", "type": "product-review publication", "relation": "portfolio" }, { "name": "NYT Games", "type": "subscription product", "relation": "portfolio" } ], "note": "The Ochs-Sulzberger Family Trust holds approximately 95% of Class B shares, which enables it to elect 70% of the board. The group earns subscription, advertising, affiliate and licensing revenue across its news and lifestyle products.", "sources": [ { "title": "New York Times 2025 annual report, filed February 2026", "url": "https://www.sec.gov/Archives/edgar/data/71691/000007169126000011/nyt-20251231.htm" } ], "reviewed": "2026-10-08" }, { "id": "thomsonreuters", "name": "Thomson Reuters", "sectors": [ "News + media" ], "ownership_structure": "Publicly traded — TRI; controlled by Woodbridge, the Thomson family’s private investment company", "children": [ { "name": "Reuters", "type": "news agency", "relation": "portfolio" }, { "name": "Reuters Connect", "type": "news-content licensing platform", "relation": "portfolio" } ], "note": "Woodbridge and its affiliates held approximately 71% of common shares as of April 13, 2026. Reuters supplies reporting to other publishers through licensing arrangements; Reuters Connect is a distribution marketplace for Reuters and partner content.", "sources": [ { "title": "Thomson Reuters 2026 management information circular", "url": "https://www.sec.gov/Archives/edgar/data/1075124/000119312526157451/d100511dex991.htm" }, { "title": "Thomson Reuters: Reuters Connect and reporting tools, July 2026", "url": "https://www.thomsonreuters.com/en-us/blog/the-tools-that-keep-reuters-journalists-and-its-customers-ahead-of-the-story/" } ], "reviewed": "2026-10-08" }, { "id": "nashholdings", "name": "Nash Holdings / Jeff Bezos", "sectors": [ "News + media" ], "ownership_structure": "Privately held; personal ownership by Jeff Bezos", "children": [ { "name": "The Washington Post", "type": "news publication", "relation": "portfolio" } ], "note": "Jeff Bezos owns The Washington Post through Nash Holdings, his private investment vehicle.", "sources": [ { "title": "Washington Post corporate ownership statement", "url": "https://company.washingtonpost.com/about" }, { "title": "Washington Post company sale completed, October 1, 2013", "url": "https://www.washingtonpost.com/business/economy/washington-post-closes-sale-to-amazon-founder-jeff-bezos/2013/10/01/fca3b16a-2acf-11e3-97a3-ff2758228523_story.html" } ], "reviewed": "2026-10-08" }, { "id": "alphabet", "name": "Alphabet / Google", "sectors": [ "Digital platforms" ], "ownership_structure": "Publicly traded — Nasdaq: GOOG / GOOGL; multiple share classes", "children": [ { "name": "YouTube", "type": "video platform", "via": "Google", "relation": "portfolio" }, { "name": "Google Search", "type": "search service", "via": "Google", "relation": "portfolio" }, { "name": "Google Ad Manager", "type": "advertising platform", "via": "Google", "relation": "portfolio" } ], "note": "Google Services combines search, video, advertising tools and subscriptions. YouTube earns advertising and subscription revenue and pays content providers through licensing and revenue arrangements.", "sources": [ { "title": "Alphabet investor guide: revenue and distribution", "url": "https://abc.xyz/investor/faqs-and-general-information/" } ], "reviewed": "2026-10-08" }, { "id": "meta", "name": "Meta Platforms", "sectors": [ "Digital platforms" ], "ownership_structure": "Publicly traded — Nasdaq: META; Mark Zuckerberg holds majority voting power", "children": [ { "name": "Facebook", "type": "social or messaging platform", "relation": "portfolio" }, { "name": "Instagram", "type": "social or messaging platform", "relation": "portfolio" }, { "name": "Messenger", "type": "social or messaging platform", "relation": "portfolio" }, { "name": "WhatsApp", "type": "social or messaging platform", "relation": "portfolio" } ], "note": "Meta’s Family of Apps includes Facebook, Instagram, Messenger and WhatsApp. Its June 2026 filing describes Mark Zuckerberg’s majority voting power and consequent control over matters submitted to shareholders.", "sources": [ { "title": "Meta June 2026 quarterly filing: products and voting control", "url": "https://www.sec.gov/Archives/edgar/data/1326801/000162828026050705/meta-20260630.htm" } ], "reviewed": "2026-10-08" }, { "id": "amazon", "name": "Amazon", "sectors": [ "Digital platforms" ], "ownership_structure": "Publicly traded — Nasdaq: AMZN", "children": [ { "name": "Prime Video", "type": "streaming service", "relation": "portfolio" }, { "name": "Twitch", "type": "livestreaming platform", "relation": "portfolio" }, { "name": "Amazon Ads", "type": "advertising business", "relation": "portfolio" } ], "note": "Amazon connects retail, video subscriptions, livestreaming and advertising. Its advertising business sells sponsored, display and video placements; its media services also earn subscription and content revenue.", "sources": [ { "title": "Amazon 2025 annual filing", "url": "https://www.sec.gov/Archives/edgar/data/1018724/000101872426000004/amzn-20251231.htm" }, { "title": "Amazon streaming advertising portfolio", "url": "https://advertising.amazon.com/solutions/products/streaming-tv-ads" } ], "reviewed": "2026-10-08" } ], "cross_links": [ { "from": "unilever", "to": "magnum", "relationship": "minority_equity_investment", "percent": 19.85, "as_of": "2026-06-30", "source": "https://www.sec.gov/Archives/edgar/data/217410/000021741026000057/R13.htm" }, { "from": "pfizer", "to": "biontech", "relationship": "commercial_collaboration", "product": "Comirnaty", "note": "Separate companies collaborating on development and commercialization. BioNTech is the marketing authorization holder in the U.S., EU, UK and other countries.", "source": "https://www.pfizer.com/news/press-release/press-release-detail/pfizer-and-biontech-receive-us-fda-approval-xfg-adapted", "as_of": "2026-10-08" }, { "from": "lilly", "to": "boehringer", "relationship": "commercial_collaboration", "product": "Jardiance", "note": "Separate companies with a development and commercialization collaboration; revenue rights and responsibilities vary by market.", "source": "https://www.sec.gov/Archives/edgar/data/59478/000005947826000081/lly-20260630.htm", "as_of": "2026-10-08" }, { "from": "elevance", "to": "cvs", "relationship": "service_contract", "product": "CarelonRx / CaremarkPCS", "note": "Elevance’s June 2026 filing states that CarelonRx delegates certain core pharmacy services to CVS subsidiary CaremarkPCS under a contract extending through December 31, 2027.", "source": "https://www.sec.gov/Archives/edgar/data/1156039/000115603926000060/elv-20260630.htm", "as_of": "2026-06-30" }, { "from": "fox", "to": "newscorp", "relationship": "shared_voting_block", "label": "LGC Holdco stakes / Murdoch voting structure", "note": "Separate public companies with a documented common voting-share holder.", "source": "https://www.sec.gov/Archives/edgar/data/1754301/000162828026062480/fox-20260917.htm", "sources": [ { "title": "Fox 2026 proxy: Class B voting rights and LGC Holdco", "url": "https://www.sec.gov/Archives/edgar/data/1754301/000162828026062480/fox-20260917.htm" }, { "title": "News Corp 2026 proxy: LGC Holdco and voting rights", "url": "https://www.sec.gov/Archives/edgar/data/1564708/000110465926109969/tm2624691-1_def14a.htm" } ], "as_of": "2026-10-08" }, { "from": "comcast", "to": "versant", "relationship": "shared_voting_controller", "label": "Brian Roberts: 33⅓% voting rights in each", "note": "Separate public companies following the January 2026 spin-off.", "source": "https://www.sec.gov/Archives/edgar/data/1166691/000119312526177138/cmcsa-20260424.htm", "sources": [ { "title": "Comcast 2026 proxy: Brian Roberts voting rights", "url": "https://www.sec.gov/Archives/edgar/data/1166691/000119312526177138/cmcsa-20260424.htm" }, { "title": "Versant 2026 proxy: Brian Roberts voting rights", "url": "https://www.sec.gov/Archives/edgar/data/2067876/000206787626000019/vsnt-20260422.htm" } ], "as_of": "2026-10-08" } ], "historical_links": [ { "from": "Bayer (pre-1925)", "to": "IG Farben", "relationship": "merger", "date": "1925", "source": "https://www.bayer.com/en/about-us/history/history-timeline" }, { "from": "BASF (pre-1925)", "to": "IG Farben", "relationship": "merger", "date": "1925", "source": "https://www.basf.com/global/en/who-we-are/history/IG-Farben" }, { "from": "IG Farben assets", "to": "Bayer", "relationship": "postwar_reestablishment", "date": "1951-12-19", "source": "https://www.bayer.com/en/about-us/history/history-timeline" }, { "from": "IG Farben assets", "to": "BASF", "relationship": "postwar_reestablishment", "date": "1952", "source": "https://www.basf.com/global/en/who-we-are/history/IG-Farben" }, { "from": "Bayer", "to": "Monsanto", "relationship": "completed_acquisition", "date": "2018-06-07", "source": "https://www.bayer.com/media/en-us/bayer-closes-monsanto-acquisition/" }, { "from": "Corteva", "to": "Vylor", "relationship": "completed_separation", "date": "2026-10-01", "source": "https://www.sec.gov/Archives/edgar/data/1755672/000175567226000028/ctva-20261001.htm" }, { "from": "Hoechst (pre-1925)", "to": "IG Farben", "relationship": "merger", "date": "1925", "source": "https://www.industriepark-hoechst.com/en/stp/site/history/" }, { "from": "IG Farben assets", "to": "Hoechst", "relationship": "postwar_reestablishment", "date": "1945–1953", "source": "https://www.industriepark-hoechst.com/en/stp/site/history/" }, { "from": "Hoechst + Rhône-Poulenc", "to": "Aventis", "relationship": "merger", "date": "1999", "source": "https://www.sec.gov/Archives/edgar/data/807198/000095012304013619/x03590bexv99w1.htm" }, { "from": "Sanofi-Synthélabo", "to": "Aventis", "relationship": "completed_acquisition", "date": "2004", "source": "https://www.sec.gov/Archives/edgar/data/807198/000095012304013619/x03590bexv99w1.htm" }, { "from": "The Cigna Group", "to": "Health Care Service Corporation", "relationship": "completed_business_sale", "businesses": "Medicare Advantage, Medicare Supplemental Benefits, Medicare Part D and CareAllies", "date": "2025-03-19", "source": "https://www.hcsc.com/newsroom/news-releases/2025/completes-cigna-medicare-acquisition" }, { "from": "Comcast", "to": "Versant Media Group", "relationship": "completed_separation", "date": "2026-01-02", "source": "https://www.sec.gov/Archives/edgar/data/2067876/000206787626000010/vsnt-20251231.htm" }, { "from": "Paramount Skydance", "to": "Warner Bros. Discovery", "relationship": "completed_acquisition", "date": "2026-10-06", "resulting_name": "Skydance", "source": "https://www.sec.gov/Archives/edgar/data/2041610/000110465926113913/tm2626659d7_ex99-1.htm" }, { "from": "ESPN", "to": "Specified NFL media assets", "relationship": "completed_acquisition", "date": "2026-01-31", "note": "NFL received a 10% interest in ESPN; Disney 72%, Hearst 18%.", "source": "https://www.sec.gov/Archives/edgar/data/1744489/000174448926000057/dis-20260627.htm" } ], "relationship_legend": { "portfolio": "Recorded brand, marketed product or operating-business association; territorial and shared rights are described in the entry.", "subsidiary": "Corporate ownership; majority and full ownership are distinguished where sourced.", "commercial_collaboration": "A contract or joint product relationship between separate companies.", "minority_equity_investment": "A dated minority stake in another company.", "historical_links": "Dated mergers, acquisitions and separations.", "service_contract": "A disclosed agreement to supply services between separate corporate groups.", "shared_voting_block": "The same holder has a documented voting stake in two listed companies.", "shared_voting_controller": "The same person has enhanced voting rights in two listed companies.", "control_records": "Dated shareholding, voting-power or board-election records.", "career_links": "Dated professional appointments between institutions." }, "announced_transactions": [ { "from": "Comcast", "businesses": "NBCUniversal and Sky", "relationship": "proposed_separation", "announced": "2026-06-29", "expected": "approximately June 2027, subject to conditions", "source": "https://www.sec.gov/Archives/edgar/data/1166691/000095010326009591/dp249094_ex9901.htm" } ], "control_records": [ { "group_id": "skydance", "controller": "Ellison family + RedBird", "mechanism": "Voting Class A stock", "detail": "Together hold 100% of voting shares of the combined company.", "as_of": "2026-10-06", "sources": [ { "title": "Skydance merger completion release, October 6, 2026", "url": "https://www.sec.gov/Archives/edgar/data/2041610/000110465926113913/tm2626659d7_ex99-1.htm" } ] }, { "group_id": "fox", "controller": "LGC Holdco / Cruden 2", "mechanism": "Class B voting block", "detail": "38.76% of Class B; votes generally directed by the Cruden 2 director appointed by Lachlan Murdoch.", "as_of": "2026-09-14", "sources": [ { "title": "Fox 2026 proxy: Class B voting rights and LGC Holdco", "url": "https://www.sec.gov/Archives/edgar/data/1754301/000162828026062480/fox-20260917.htm" } ] }, { "group_id": "newscorp", "controller": "LGC Holdco / Cruden 2", "mechanism": "Class B voting block", "detail": "34.8% of Class B; votes generally directed by the Cruden 2 director appointed by Lachlan Murdoch.", "as_of": "2026-08-28", "sources": [ { "title": "News Corp 2026 proxy: LGC Holdco and voting rights", "url": "https://www.sec.gov/Archives/edgar/data/1564708/000110465926109969/tm2624691-1_def14a.htm" } ] }, { "group_id": "comcast", "controller": "Brian L. Roberts", "mechanism": "Enhanced Class B voting rights", "detail": "Generally non-dilutable 33⅓% of combined voting power.", "as_of": "2026-04-08", "sources": [ { "title": "Comcast 2026 proxy: Brian Roberts voting rights", "url": "https://www.sec.gov/Archives/edgar/data/1166691/000119312526177138/cmcsa-20260424.htm" } ] }, { "group_id": "versant", "controller": "Brian L. Roberts", "mechanism": "Enhanced Class B voting rights", "detail": "Generally non-dilutable 33⅓% of combined voting power.", "as_of": "2026-04-14", "sources": [ { "title": "Versant 2026 proxy: Brian Roberts voting rights", "url": "https://www.sec.gov/Archives/edgar/data/2067876/000206787626000019/vsnt-20260422.htm" } ] }, { "group_id": "nytimes", "controller": "Ochs-Sulzberger Family Trust", "mechanism": "Board-election rights", "detail": "Approximately 95% of Class B shares; ability to elect 70% of directors.", "as_of": "2025-12-31", "sources": [ { "title": "New York Times 2025 annual report, filed February 2026", "url": "https://www.sec.gov/Archives/edgar/data/71691/000007169126000011/nyt-20251231.htm" } ] }, { "group_id": "thomsonreuters", "controller": "Woodbridge / Thomson family", "mechanism": "Majority common-share ownership", "detail": "Approximately 71% of common shares.", "as_of": "2026-04-13", "sources": [ { "title": "Thomson Reuters 2026 management information circular", "url": "https://www.sec.gov/Archives/edgar/data/1075124/000119312526157451/d100511dex991.htm" } ] }, { "group_id": "nashholdings", "controller": "Jeff Bezos", "mechanism": "Private ownership", "detail": "The Washington Post is personally held through Nash Holdings.", "as_of": "2026-10-08", "sources": [ { "title": "Washington Post corporate ownership statement", "url": "https://company.washingtonpost.com/about" }, { "title": "Washington Post company sale completed, October 1, 2013", "url": "https://www.washingtonpost.com/business/economy/washington-post-closes-sale-to-amazon-founder-jeff-bezos/2013/10/01/fca3b16a-2acf-11e3-97a3-ff2758228523_story.html" } ] }, { "group_id": "meta", "controller": "Mark Zuckerberg", "mechanism": "Majority voting power", "detail": "Voting control over matters submitted to shareholders, including director elections.", "as_of": "2026-06-30", "sources": [ { "title": "Meta June 2026 quarterly filing: products and voting control", "url": "https://www.sec.gov/Archives/edgar/data/1326801/000162828026050705/meta-20260630.htm" } ] } ], "career_links": [ { "person": "Andy Slavitt", "path": "Optum → CMS", "dates": "June 2014; acting administrator in 2015", "text": "Optum’s former group executive vice president joined CMS in 2014 and later became acting administrator.", "sources": [ "https://docs.house.gov/meetings/IF/IF02/20140731/102587/HHRG-113-IF02-Bio-SlavittA-20140731.pdf", "https://www.finance.senate.gov/chairmans-news/hatch-on-nomination-of-andy-slavitt-to-head-the-centers-for-medicare-and-medicaid-services" ] }, { "person": "Marilyn Tavenner", "path": "CMS → AHIP", "dates": "February–July 2015", "text": "After leaving CMS in February 2015, Tavenner was elected president and CEO of America’s Health Insurance Plans on July 15, 2015.", "sources": [ "https://www.sec.gov/Archives/edgar/data/1301611/000110465915054380/a15-16551_1ex99d1.htm" ] }, { "person": "Scott Gottlieb", "path": "FDA → Pfizer board", "dates": "2017–2019; June 27, 2019", "text": "After serving as FDA commissioner from 2017 to 2019, Gottlieb joined Pfizer’s board on June 27, 2019, including its regulatory-and-compliance and science-and-technology committees.", "sources": [ "https://www.pfizer.com/news/press-release/press-release-detail/scott_gottlieb_elected_to_pfizer_s_board_of_directors" ] } ] }